Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.9%

1 terminated out of 54 trials

Success Rate

97.0%

+10.5% vs benchmark

Late-Stage Pipeline

15%

8 trials in Phase 3/4

Results Transparency

13%

4 of 32 completed with results

Key Signals

4 with results97% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (21)
Early P 1 (2)
P 1 (3)
P 2 (2)
P 3 (1)
P 4 (7)

Trial Status

Completed32
Unknown13
Recruiting3
Active Not Recruiting2
Not Yet Recruiting2
Terminated1

Trial Success Rate

97.0%

Benchmark: 86.5%

Based on 32 completed trials

Clinical Trials (54)

Showing 20 of 20 trials
NCT06876467Recruiting

Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus

NCT07517068Early Phase 1Active Not Recruiting

The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude

NCT05313139CompletedPrimary

Surveillance of Vaccine-induced Immunity Against Ebola in Previously Vaccinated Health Care Workers

NCT07467590Phase 2Not Yet Recruiting

Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study

NCT05534893Not ApplicableCompletedPrimary

Effect of Blueberries on Immunity

NCT07347769Not Yet Recruiting

Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy

NCT07178483Active Not Recruiting

Evaluation of Physical Capacity and Energy Requirements in Patients With Hypoxemic Acute Respiratory Failure

NCT06404749Not ApplicableTerminated

Fungal Fiber for Gut Health

NCT04274348Not ApplicableCompleted

Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum

NCT02872311Not ApplicableCompletedPrimary

Open-Label Influenza Vaccine Evaluation

NCT04866576Not ApplicableCompleted

Effect of a Fermented Soy Product on Cognition, Immune Status and Vaccine

NCT05031663Not ApplicableCompletedPrimary

Effect of Almonds on Immune Strength and Response to Flu Vaccination in Overweight Older Men and Postmenopausal Women: A Randomized Controlled Study

NCT06837961Phase 3Completed

LC-Plasma on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Diseases

NCT06041867Not ApplicableCompletedPrimary

Agaricus Bisporus and Influenza Vaccination Response

NCT05915390Not ApplicableCompletedPrimary

Walnut and Immunity Study

NCT06159556Not ApplicableCompletedPrimary

Effects of Peanuts on Immunity and Cardiometabolic Risk Factors

NCT05208060Phase 1UnknownPrimary

Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells

NCT06512896Not ApplicableRecruiting

Clinical Study on Intraluminal Injection of FOLactis

NCT05102669Completed

Spike-specific Cellular Immune Response After COVID-19 Vaccination

NCT05970887Phase 4CompletedPrimary

Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines

Scroll to load more

Research Network

Activity Timeline